Missed GME or NVDA? Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
PRGO Stock Forecast 2025-2026
$27.53
Current Price
$3.78B
Market Cap
Buy 3
Hold 2
Sell 0
Wall St Analyst Ratings
Distance to PRGO Price Targets
+52.6%
To High Target of $42.00
+32.6%
To Median Target of $36.50
+12.6%
To Low Target of $31.00
PRGO Price Momentum
+3.0%
1 Week Change
+3.3%
1 Month Change
+0.2%
1 Year Change
+7.1%
Year-to-Date Change
-11.0%
From 52W High of $30.93
+19.0%
From 52W Low of $23.14
📊 TOP ANALYST CALLS
Did PRGO Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Perrigo is one of their latest high-conviction picks.
Latest PRGO Stock Price Targets & Analyst Predictions
Based on our analysis of 17 Wall Street analysts, PRGO has a bullish consensus with a median price target of $36.50 (ranging from $31.00 to $42.00). Currently trading at $27.53, the median forecast implies a 32.6% upside. This outlook is supported by 3 Buy, 2 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Susan Anderson at Canaccord Genuity, projecting a 52.6% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
PRGO Analyst Ratings
3
Buy
2
Hold
0
Sell
PRGO Price Target Range
Low
$31.00
Average
$36.50
High
$42.00
Current: $27.53
Latest PRGO Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for PRGO.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Jan 6, 2025 | Piper Sandler | Korinne Wolfmeyer | Neutral | Downgrade | $27.00 |
| Sep 30, 2024 | Canaccord Genuity | Susan Anderson | Buy | Maintains | $42.00 |
| Sep 23, 2024 | Jefferies | Keith Devas | Hold | Downgrade | $30.00 |
| Jul 11, 2024 | Piper Sandler | Korinne Wolfmeyer | Overweight | Maintains | $35.00 |
| Jun 13, 2024 | Piper Sandler | Korinne Wolfmeyer | Overweight | Maintains | $36.00 |
| Apr 12, 2024 | Canaccord Genuity | Susan Anderson | Buy | Maintains | $42.00 |
| Apr 8, 2024 | Piper Sandler | Korinne Wolfmeyer | Overweight | Maintains | $39.00 |
| Feb 28, 2024 | JP Morgan | Chris Schott | Overweight | Maintains | $41.00 |
| Nov 17, 2023 | Piper Sandler | Korinne Wolfmeyer | Overweight | Initiates | $37.00 |
| Aug 9, 2023 | JP Morgan | Chris Schott | Overweight | Maintains | $48.00 |
| Mar 7, 2023 | Canaccord Genuity | Susan Anderson | Buy | Initiates | $49.00 |
| Mar 6, 2023 | Raymond James | Elliot Wilbur | Outperform | Maintains | $43.00 |
| Nov 9, 2022 | Raymond James | Elliot Wilbur | Outperform | Maintains | $42.00 |
| Sep 14, 2022 | Argus Research | Kristina Ruggeri | Buy | Upgrade | $46.00 |
| Sep 6, 2022 | Wells Fargo | Jacob Hughes | Overweight | Upgrade | $54.00 |
| May 4, 2022 | Raymond James | Elliot Wilbur | Outperform | Maintains | $48.00 |
| Nov 11, 2021 | Raymond James | Elliot Wilbur | Outperform | Maintains | $55.00 |
| Oct 14, 2021 | Raymond James | Outperform | Upgrade | $0.00 | |
| Sep 30, 2021 | Jefferies | David Steinberg | Buy | Upgrade | $63.00 |
| Mar 5, 2021 | Morgan Stanley | David Risinger | Equal-Weight | Maintains | $45.00 |
Perrigo Company plc (PRGO) Competitors
The following stocks are similar to Perrigo based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Perrigo Company plc (PRGO) Financial Data
Perrigo Company plc has a market capitalization of $3.78B with a P/E ratio of 2,818.0x. The company generates $4.34B in trailing twelve-month revenue with a -4.2% profit margin.
Revenue growth is -3.5% quarter-over-quarter, while maintaining an operating margin of +8.1% and return on equity of -3.6%.
Valuation Metrics
Market Cap
$3.78B
Enterprise Value
$7.10B
P/E Ratio
2,818.0x
PEG Ratio
8.8x
Price/Sales
0.9x
Growth & Margins
Revenue Growth (YoY)
-3.5%
Gross Margin
+37.6%
Operating Margin
+8.1%
Net Margin
-4.2%
EPS Growth
-3.5%
Financial Health
Cash/Price Ratio
+10.8%
Current Ratio
2.4x
Debt/Equity
87.9x
ROE
-3.6%
ROA
+2.9%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Perrigo Company plc (PRGO) Business Model
About Perrigo Company plc
What They Do
Global provider of OTC consumer healthcare products.
Business Model
Perrigo generates revenue by manufacturing and distributing over-the-counter consumer healthcare products, including vitamins, dietary supplements, and personal care items. The company focuses on providing affordable alternatives to brand-name drugs, which attracts a diverse consumer base looking for effective and cost-efficient health solutions.
Additional Information
Headquartered in Dublin, Ireland, Perrigo serves various global markets and collaborates with healthcare institutions and retail channels. The company emphasizes innovation and quality assurance, adapting its products to meet changing consumer needs and regulatory standards, thereby playing a significant role in enhancing public health and wellness.
Company Information
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
9,140
CEO
Mr. Patrick Lockwood-Taylor
Country
Ireland
IPO Year
1991
Website
www.perrigo.comPerrigo Company plc (PRGO) Latest News & Analysis
Featured Analysis
Powered by
Zacks Investment Research
Should Value Investors Buy Perrigo (PRGO) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Jul 09, 2025
By Zacks Equity Research
Tale of the Tape
Latest News
Quick Summary
Zacks highlights its Zacks Rank system, prioritizing earnings estimates and revisions to identify strong stocks, while also monitoring value, growth, and momentum trends.
Why It Matters
The emphasis on earnings estimates and revisions signals potential stock performance trends, guiding investors toward promising opportunities in value, growth, and momentum stocks.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Starting July 1, 2025, Good Start® | Dr. Brown's™ will hold a contest awarding 100 winners baby formula and products, while also donating to Baby2Baby to support families in need.
Why It Matters
The giveaway initiative could boost brand loyalty and visibility for Good Start® and Dr. Brown's™, potentially increasing sales and market share in the competitive baby formula sector.
Source: PRNewsWire
Market Sentiment:
Neutral
Perrigo Announces Strategic Organizational Update to Drive Sustainable Growth and Performance
12 days ago
Quick Summary
Perrigo Company announced a new global growth strategy focusing on Category Leadership and Market Activation, appointing Roberto Khoury as EVP & Chief Commercial Officer. Triona Schmelter will leave the company.
Why It Matters
Perrigo's leadership changes and growth strategy indicate a focus on agility and innovation, potentially enhancing market position and long-term profitability, which can positively impact stock performance.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
Dividend stocks are crucial for income generation in an investor's portfolio, providing a steady cash flow.
Why It Matters
Dividend stocks provide a steady income stream, enhancing portfolio stability and attracting income-focused investors, especially in volatile markets.
Source: MarketBeat
Market Sentiment:
Positive
Quick Summary
Perrigo (PRGO) has a consensus price target indicating a 32.9% upside potential, supported by positive earnings estimate revisions, suggesting possible near-term gains.
Why It Matters
The 32.9% upside potential suggests significant growth for Perrigo (PRGO), while rising earnings estimates indicate positive momentum, potentially attracting investor interest.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Perrigo (PRGO) reported earnings 30 days ago; investors should monitor upcoming developments and analyses for potential stock movements.
Why It Matters
Perrigo's earnings report can influence stock performance and investor sentiment. Future guidance or market reactions may impact share price and investment strategies.
Source: Zacks Investment Research
Market Sentiment:
Negative
Frequently Asked Questions About PRGO Stock
What is Perrigo Company plc's (PRGO) stock forecast for 2026?
Based on our analysis of 17 Wall Street analysts, Perrigo Company plc (PRGO) has a median price target of $36.50. The highest price target is $42.00 and the lowest is $31.00.
Is PRGO stock a good investment in 2026?
According to current analyst ratings, PRGO has 3 Buy ratings, 2 Hold ratings, and 0 Sell ratings. The stock is currently trading at $27.53. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for PRGO stock?
Wall Street analysts predict PRGO stock could reach $36.50 in the next 12 months. This represents a 32.6% increase from the current price of $27.53. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Perrigo Company plc's business model?
Perrigo generates revenue by manufacturing and distributing over-the-counter consumer healthcare products, including vitamins, dietary supplements, and personal care items. The company focuses on providing affordable alternatives to brand-name drugs, which attracts a diverse consumer base looking for effective and cost-efficient health solutions.
What is the highest forecasted price for PRGO Perrigo Company plc?
The highest price target for PRGO is $42.00 from Susan Anderson at Canaccord Genuity, which represents a 52.6% increase from the current price of $27.53.
What is the lowest forecasted price for PRGO Perrigo Company plc?
The lowest price target for PRGO is $31.00 from at , which represents a 12.6% increase from the current price of $27.53.
What is the overall PRGO consensus from analysts for Perrigo Company plc?
The overall analyst consensus for PRGO is bullish. Out of 17 Wall Street analysts, 3 rate it as Buy, 2 as Hold, and 0 as Sell, with a median price target of $36.50.
How accurate are PRGO stock price projections?
Stock price projections, including those for Perrigo Company plc, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: July 13, 2025 5:39 PM UTC